Custom Search

Progression of Eye Damage in Diabetics Could be Slowed by BP Drug

Category: Drug News RSS
Sunday, July 05, 2009 at 10:31:28 AM
Bookmark and Share     Font Size 
A drug commonly prescribed to treat high blood pressure, could slow the progression of eye damage in people with type 1 diabetes, a new study has said.

By administering an antihypertensive, University of Minnesota Medical School researcher Michael Mauer, M.D. and colleagues were able to slow progression of diabetic eye damage in more than 65 percent of participants involved in the study.

Three groups of participants were observed over the course of five years. Two groups were administered one of two antihypertensive medications, losartan or enalapril, and the last group, a placebo.

Mauer's study demonstrated that participants who were administered either enalapril or losartan experienced a significant slowing of the progression of diabetic eye injury, by 65 and 70 percent, respectively.

"The secondary results of this study showed that people taking these antihypertensive medications experienced a substantially positive effect in slowing diabetic eye injury," said Mauer.

The study has been published in the July 2nd issue of The New England Journal of Medicine.

Source-ANI
RAS
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Be the first to comment
* Your comment can be maximum of 2500 characters
Notify me when reply is posted   

Related Links

Tweet this page Share this page
500 + Health news categories
Latest Health News From Leading Resources
Updated every 30 minutes
Eye
Complete Medindia Resources
World Diabetes Day
Select a News Category
News Archive
Date :
Category :
Keyword :
Medindia on Facebook
Feedback  Advanced Search
Last Updated - - Designed & Content Managed by Medindia Health Network Pvt Ltd. Hosted & Technical Support by FrontPoint Systems
DisclaimerThe contents of this site are for informational purposes only. Always seek the advice of a qualified physician for any doubts.
To Read full Disclaimer Click Here!
Best viewed with resolution 1024x768 px.
Advertise with us |  Medindia Copyright |  Privacy Policy | Terms of Use |  © All Rights Reserved 1997 - 2009